{
    "nctId": "NCT02935920",
    "briefTitle": "A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy",
    "officialTitle": "A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 134,
    "primaryOutcomeMeasure": "The difference in PREM (patient reported experience measure) as reported by patients in the individualized and standard follow-up groups, respectively",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal at the time of diagnosis (menostasis \\> 12 months. Bilateral salpingo-oophorectomy)\n* Complete disease remission after primary operation\n* Histologically confirmed hormone-receptor positive breast cancer, 1% or more of the tumor cells express hormone receptors\n* High-risk profile with a 10-year recurrence of more than 10%\n* Planned adjuvant endocrine therapy regardless of other adjuvant therapy to be initiated within 1 month or initiated within the last 9 months.\n* Written and verbally informed consent\n* Able to read and speak Danish\n* Access to a computer and an email-account\n\nExclusion Criteria:\n\n* Patient followed regularly as part of a research protocol\n* Women postmenopausal due to surgery on the ovaries/uterus age \\< 50\n* Prognostic low grade risk of recurrence (tumor size 10 mm or less, lymph node negative, ductal carcinoma grade 1 and lobular carcinoma grade 1 or 2)",
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}